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Summary.-Average annual age-adjusted mortality rates per 100,000 from primary
hepatic carcinoma (PHC) among males for 1971-1973 in the urban and rural areas
of the 9 geographical regions of Greece were estimated. Hepatitis-B surface antigen
(HBsAg) prevalence by region and area was evaluated in a sample of 22,844 Greek
Air Force recruits from all parts of the country. Mortality from PHC was found
significantly higher in urban areas (28-30 vs. 18.81) whereas prevalence of HBsAg
was higher in rural areas (5.37% vs.3.90%). Nevertheless further statistical analysis
showed that there is a strong correlation between HBsAg prevalence and mortality
from PHC, which is higher in rural (r --+ 0.88) than in urban (+ 0.57) areas. The
latter findings indicate that hepatitis B infection and PHC may be causally related.
THE association between hepatitis-B
virus (HBV) infection and primary hepatic
carcinoma (PHC) is supported by observa-
tions on the natural history of chronic
liver disease (Sherlock et al., 1970; Hadzi-
yannis, Merikas and Afroudakis, 1970) as
well as by findings of studies showing
a greater than expected prevalence of
hepatitis-B surface antigen (HBsAg)
(Vogel et al., 1972; Blumberg et al.,
1975) and antibody to hepatitis-B core
antigen in patients with PHC (Maupas et
at., 1975). Although this association seems well
documented, at least in areas of the
world with high incidence of PHC, there
is some doubt about the causal nature
of the relationship. Indeed the associa-
tion could be secondary, or the PHC
and the frequently related chronic liver
disease could facilitate the establishment
of persistent antigenaemia (Kumar and
Taylor, 1973; Linsell, 1975; Coady, 1975).
Population correlation between pre-
valence of HBsAg and incidence of PHC
could be considered as further evidence
of the aetiological significance of HBV
infection in the development of PHC.
Indeed it was found that the prevalence
of HBsAg is high in the general popula-
tion of areas such as Africa and Greece
where PHC is very common (British
Medical Journal, 1975; Trichopoulos et
al., 1975). However, the validity of this
international population correlation is
questionable, since the compared popula-
tions are very different in many aspects
and the data concerning the prevalence
of HBsAg and the incidence of PHC
are not strictly comparable. Clearly geo-
graphical correlations based on homo-
geneouspopulationgroups and comparable
data would have greater value. It is of
interest that there has been only one
study of this nature, in the Muranga
district of Kenya, based on a relatively
small sample, and this has shown no
significant difference ofHBsAg prevalence
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between areas of high and low incidence
of PHC (Bagshawe et al., 1975).
The present study was designed to
investigate the geographical correlation
between HBsAg prevalence and PHC
mortality in the various regions of
Greece.
SUBJECTS AND METHODS
Prevalence ofHBsAg.-Between 1971 and
1975 22,844 Greek Air Force recruits were
screened for HBsAg at the time of their
enlistment. Their age varied between 18
and 22 years. The recruits were classified
according to their permanent residence in
urban (cities or towns of more than 10,000
inhabitants) or rural (villages or towns of
less than 10,000 inhabitants) areas of the
nine main geographical regions of Greece.
Sera were collected aseptically and stored
at-20°C until tested. HBsAg was detected
by counterimmunoelectrophoresis (Pesendor-
fer, Krassnitzky and Wewalka, 1970).
Mortality from PHC.-Population data
from the 1971 census and death certificates
for the years 1971, 1972 and 1973, compiled
TABLE.-Male Populatio
1973) and Prevalence
Place of Residence in
Greece
Geographical region
and area
Central Greece: urban
rural
Peloponnesos: urban
rural
Ionian Islands: urban
rural
Epirus: urlian
rural
Thessaly: urban
rural
Macedonia: urban
rural
Thrace: urban
rural
Aegean Islands: urban
rural
Crete: urban
rural
Greece, Total: urban
rural
Grand Total
by the health services branch of the Ministry
of Social Services, were used to estimate
average annual age-specific mortality rates
among males from cause 155 of the Inter-
national Classification of Diseases of the
World Health Organization, 1965 revision
(malignant neoplasms of liver and intra-
hepatic bile ducts, specified as primary).
Although most PHC cases are treated in
major hospitals of the larger cities, deaths
are classified according to the place of
permanent residence. Annual mortality
rates from PRC by geographic region and
urban-rural areas within region were age-
adjusted to the distribution of the total
male population of Greece ofthe 1971 census
(Trichopoulos et al., 1974).
RESULTS
The prevalence of HBsAg among
Greek Air Force recruits was 4-46%. It
was significantly higher in rural (5-37%)
than in urban (3-90%) areas (P < 0-001).
The average annual mortality rate from
PHC per 100,000 male population was
23-12. It was significantly higher in
n, Average Annual Mortality from PHC among Males (1971-
of HBsAg among Greek Air Force Recruits (1971-1975) by
Urban or Rural Areas of the Nine Geographical Regions of
Male
population
(census 1971)
1,352,680
355,140
146,020
345,320
15,580
71,460
36,280
111,940
115,540
203,840
433,840
507,580
49,300
113,100
49,400
151,420
75,660
145,960
2,274,300
2,005,760
4,280,060
Mortality*
from PHC
(per 100,000)
28-26
19-12
23 - 67
15-64
27-80
17-15
26-23
20-20
34-89
22 -98
29-66
23 -51
25-31
23-96
30-15
12 -05
21 -47
13 -25
28-30
18-81
23-12
Prevalence of HBsAg
Number Number of %
examined carriers carriers
7,770 249 3 -20
1,597 77 4- 82
1,211 51 4-21
1,903 66 3-47
78 1 1-28
269 8 2 -97
280 8 2 -86
476 22 4- 62
1,049 67 6 -39
1,115 66 5-92
2,697 144 5.34
1,853 159 8 58
192 8 4-17
409 34 8-31
222 8 3-60
572 18 3-15
615 15 2-44
536 17 3-17
14,164 552 3-90
8,680 466 5-37
22,844 1,018 4-46
* Rates are age-adjusted to the distribution of the total male population of Greece.
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L
Prevalence (a/.) of HBsAg (x)
FIG. Linear regression lines of annual
mortality (per 100,000) from PHC on
prevalence (per cent) of HBsAg in urban
(1) and rural (2) areas of the nine geo-
graphical regions of Greece.
urban (28.30) than in rural (18.81) areas
(P < 0.001).
The Table shows the average age-
adjusted annual mortality rates from
PHR among males in the urban and
rural areas of the 9 geographic regions
of Greece. It shows also the prevalence
of HBsAg among Greek Air Force recruits
by place of permanent residence as
above.
Covariance analysis (Armitage, 1971)
showed that the slopes of the regression
lines (Fig.) of mortality from PHC on
HBsAg prevalence in urban (1-47 ± 0.80)
and rural (1.79 0.37) areas were not
significantly different (P > 0 40). The
estimated common slope (b - 1-68 ± 0 39)
is significantly different from zero
(P < 0.001).
The correlation coefficient between
the two variables is +0-88 in rural and
+0 57 in urban areas with a common
estimate of +0-76, which is again signifi-
cantly different from zero (P < 0-001).
If the urban-rural difference in the
prevalence of HBsAg is allowed for,
the difference between the mean mortality
from PHC in urban and rural areas is
further increased. The adjusted differ-
ence (Armitage, 1971) in mortality from
PHC between urban and rural areas
is 10*99 ± 1-42 and differs significantly
from zero (P < 0.001).
DISCUSSION
The high prevalence of HBsAg in
Greece has been noted by several authors
(Hadziyannis et at., 1973). It is of interest
that this prevalence is higher in rural
than in urban areas, a fact which could
be attributed to the lower hygiene
standards of the rural population (Cheru-
bin, 1971).
The estimated annual mortality rate
from PHC is much higher than that
prevailing in other European countries
(I.U.A.C., 1966).
There are certain limitations in the
mortality data. In Greece the majority
of PHC cases are diagnosed on clinical
grounds, since autopsies are rarely per-
formed and alpha-foetoprotein determina-
tions are not routinely performed in
most hospitals. It seems likely however
that the possible errors are not related
to the regional distribution of HBsAg
and this substantially decreases the possi-
bility that the association is not real.
Therefore, the present study helps to
establish that there is a geographical
correlation between HBsAg prevalence
and mortality from (and hence incidence
of) PHC.
Many problems complicate the inter-
pretation of correlation studies. Diffi-
culties arise from the use of populations
as sampling units, the long latent interval
for most human cancers, and the presence
of multiple aetiologic agents. They have
recently been discussed by Breslow and
Enstrom (1974). However, the demon-
stration of a population correlation be-
tween HBsAg and PHC helps to eliminate
a number of alternative explanations for
the association of these two factors in
individuals.
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The population correlation cannot be
explained in terms of a tumour effect
on the establishment of persistent hepa-
titis-B antigenaemia. The incidence of
PHC and of the frequently associated
cirrhosis are in general too low to affect
the HBsAg prevalence. Also these dis-
eases develop late in life, while in the
present study HBsAg prevalence was
estimated in 18-22-year-old males.
It is also less likely (although still
possible) that confounding factors would
explain the association between HBsAg
and PHC in individuals as well as the
international correlation and the geo-
graphical correlation within Greece. Fur-
thermore, various infections which may
affect the incidence of PHC as well as
the immunological response to HBV
(Dudley, Fox and Sherlock, 1972; Zucker-
man, 1972; Coady, 1975) are not en-
countered in Greece as frequently as
in Africa and other parts of the world
(WHO Annual, 1975). This is also
probably true for aflatoxin (Peers and
Linsell, 1973), although sufficient data
are not available for Greece.
Peers and Linsell (1973) found a
near-linear relation between PHC in-
cidence and log aflatoxin intake in the
Muranga district of Kenya, whereas Bag-
shawe et al. (1975) failed to detect a
significant difference in HiBsAg prevalence
between areas with contrasting incidence
of PHC. These findings are not incom-
patible with the results of the present
study. PHC is probably a disease of
multifactorial origin (Higginson and Svo-
boda, 1970) and it is conceivable that a
particular pattern of the disease is attri-
butable to one factor, whereas another
pattern is explained in terms of another
factor. It may also be noted that
Bagshawe et al. (1975) did find a higher
HBsAg prevalence in the areas with
higher incidence of PHC although the
difference was not statistically significant
(3.6% VS. 27%).
In Greece since the last war a strong
wave of internal migration from the
villages towards the cities has increased
the proportion of urban population from
32.8o% in 1940 to 53.2% in 1972 (Tricho-
poulos et al., 1974). This fact and the
probably long latent period of PHC may
help to explain the higher correlation
found in rural areas, where the population
is more stable and to a higher proportion
locally born. Regression lines of morta-
lity from PHC on prevalence of HBsAg
in urban and rural areas of Greece are
parallel, but they differ by about 11
deaths annually per 100,000 population.
This implies that irrespective of HBsAg
prevalence the mortality from PHC in
urban areas is higher than in rural by
about 60%. This difference cannot be
entirely explained in terms of the better
diagnostic facilities available in the towns,
since, as already mentioned, most cancer
patients are hospitalized in major cities.
It would appear, therefore, that in Greece
and particularly in urban areas additional
factors of aetiologic importance are pre-
sent and they are partly responsible for
the excessively high incidence of PHC in
this country.
This study was supported by a grant
from the GreekMinistry ofSocial Services.
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